Koyfin Home > Directory > Health Care > Antares Pharma > Total Revenue

Antares Pharma Total Revenue Chart (ATRS)

Antares Pharma annual/quarterly Total Revenue from 2000 to 2018. Revenue is the money that a business receives from its normal business activities, usually from the sale of goods and services to customers.
  • Antares Pharma Total Revenue for the quarter ending December 12, 2018 was $19m a 32.51% increase of 6m year over year
  • Antares Pharma Total Revenue for the last 12 months ending December 12, 2018 was $64m a 13.13% increase of 8m year over year
  • Antares Pharma Annual Total Revenue for 2018 was $64m a 14.22% increase of 9m from 2017
  • Antares Pharma Annual Total Revenue for 2017 was $55m a 4.21% increase of 2m from 2016
  • Antares Pharma Annual Total Revenue for 2016 was $52m a 12.57% increase of 7m from 2015
Other Income Statement Metrics:
  • Antares Pharma EBITDA for the quarter ending December 12, 2018 was $-5m a 1.88% decrease of 0m year over year
  • Antares Pharma Net Income for the quarter ending December 12, 2018 was $6m a 200.96% increase of 12m year over year
View Chart On Koyfin

Quarterly ATRS Total Revenue Data

12/2018$19m
09/2018$18m
06/2018$14m
03/2018$13m
12/2017$14m
09/2017$15m
06/2017$13m
03/2017$12m
12/2016$14m
09/2016$13m

Annual ATRS Total Revenue Data

2018$64m
2017$55m
2016$52m
2015$46m
2014$27m
2013$21m
2012$23m
2011$16m
2010$13m
2009$8m